22157.jpg
Global Cancer Vaccine Partnering Terms and Agreements Analysis Report 2023: Everything to Know About Partnering in the R&D and Commercialization of Cancer Vaccine Technologies and Products
June 06, 2023 03:48 ET | Research and Markets
Dublin, June 06, 2023 (GLOBE NEWSWIRE) -- The "Global Cancer Vaccine Partnering Terms and Agreements 2010-2023" report has been added to ResearchAndMarkets.com's offering.The Global Cancer Vaccine...
22157.jpg
Cancer Vaccine Global Market Report 2023: Technological Advancement in Healthcare Sectors Presents Opportunities
May 16, 2023 05:03 ET | Research and Markets
Dublin, May 16, 2023 (GLOBE NEWSWIRE) -- The "Cancer Vaccine Market by Technology, Type, Disease Indication, and End User: Global Opportunity Analysis and Industry Forecast, 2023-2030." report has...
Logo.png
Cancer Vaccines Clinical Trial Pipeline Analysis Demonstrates 250+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight
May 15, 2023 13:00 ET | DelveInsight Business Research LLP
New York, USA, May 15, 2023 (GLOBE NEWSWIRE) -- Cancer Vaccines Clinical Trial Pipeline Analysis Demonstrates 250+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses...
22157.jpg
Global Cancer Vaccines Competitive Landscape Report 2023: Comprehensive Insights About 250+ Companies and 300+ Drugs
May 03, 2023 07:08 ET | Research and Markets
Dublin, May 03, 2023 (GLOBE NEWSWIRE) -- The "Cancer Vaccines - Competitive landscape, 2023" report has been added to ResearchAndMarkets.com's offering. This "Cancer Vaccines - Competitive...
Contrive Datum Insights_Logo.jpg
Cancer Immunotherapy Market Is Expected to Reach $309.67 Billion by 2030, Grow at a CAGR Of 9.6% during Forecast Period 2023 To 2030 | Data By Contrive Datum Insights Pvt Ltd.
April 11, 2023 15:22 ET | Contrive Datum Insights Pvt Ltd
Farmington, April 11, 2023 (GLOBE NEWSWIRE) -- The Global Cancer Immunotherapy Market Was Valued At $85.6 Billion In 2022 And Is Expected To Expand  $309.67 Billion By 2030 at a CAGR Of 9.6% From...
Cancer Vaccines GNW_1_11zon.jpg
Global Cancer Vaccine Market to Generate USD 13.4 Billion by 2030, Outlines a New Report by Next Move Strategy Consulting
March 23, 2023 09:00 ET | Next Move Strategy Consulting
New York, March 23, 2023 (GLOBE NEWSWIRE) -- According to a report published by Next Move Strategy Consulting, the global Cancer Vaccine Market generated USD 5.75 billion in 2022 and is projected to...
Cancer Vaccines Market Size Expected to Hit USD 19.12 Billion by 2029, exhibiting a CAGR of 14.7%
March 09, 2023 07:50 ET | Fortune Business Insights
Pune, India, March 09, 2023 (GLOBE NEWSWIRE) -- The global cancer vaccines market size was valued at USD 6.43 billion in 2021. The market is expected to grow from USD 7.32 billion in 2022 to USD...
22157.jpg
Global Human Papillomavirus Vaccine Market Research Report 2022: Upsurge in the Cases of HPV Related Diseases Driving Research Activities - Competition, Opportunities & Forecasts to 2027
February 23, 2023 05:03 ET | Research and Markets
Dublin, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The "Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Valence (Bivalent,...
AMR Logo.png
HPV Testing and Pap Test Market is Expected to Reach $6.7 Billion by 2031: Allied Market Research
February 06, 2023 03:21 ET | Allied Market Research
Portland, OR, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Based on the research carried out by Allied Market Research, the global HPV Testing And Pap Test Market generated USD 3.7 billion in 2021, and is...
European Human Papillomavirus (HPV) Vaccine Market
Europe Human Papillomavirus Vaccine Market Report 2022: Increase in Prevalence of HPV Associated Diseases Boosts Demand
January 26, 2023 06:54 ET | Research and Markets
Dublin, Jan. 26, 2023 (GLOBE NEWSWIRE) -- The "Europe Human Papillomavirus Vaccine Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Dosage, Age, Application, and End User"...